These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 12523630)
1. A clinical strain of Escherichia coli possessing CMY-2 plasmid-mediated amp C beta-lactamase: an emerging concern in pediatrics? Hoyen CM; Hujer AM; Hujer KM; Marshall SH; Carias L; Toltzis P; Rice LB; Bonomo RA Microb Drug Resist; 2002; 8(4):329-33. PubMed ID: 12523630 [TBL] [Abstract][Full Text] [Related]
2. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC. Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329 [TBL] [Abstract][Full Text] [Related]
3. Comparison of broad-spectrum cephalosporin-resistant Escherichia coli isolated from dogs and humans in Hokkaido, Japan. Okubo T; Sato T; Yokota S; Usui M; Tamura Y J Infect Chemother; 2014 Apr; 20(4):243-9. PubMed ID: 24709044 [TBL] [Abstract][Full Text] [Related]
4. Characterization of blaCMY-11, an AmpC-type plasmid-mediated beta-lactamase gene in a Korean clinical isolate of Escherichia coli. Lee SH; Kim JY; Lee GS; Cheon SH; An YJ; Jeong SH; Lee KJ J Antimicrob Chemother; 2002 Feb; 49(2):269-73. PubMed ID: 11815567 [TBL] [Abstract][Full Text] [Related]
5. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity. Göttig S; Hamprecht AG; Christ S; Kempf VA; Wichelhaus TA J Antimicrob Chemother; 2013 Aug; 68(8):1737-40. PubMed ID: 23557929 [TBL] [Abstract][Full Text] [Related]
6. A survey of β-lactamase and 16S rRNA methylase genes among fluoroquinolone-resistant Escherichia coli isolates and their horizontal transmission in Shandong, China. Xia LN; Tao XQ; Shen JZ; Dai L; Wang Y; Chen X; Wu CM Foodborne Pathog Dis; 2011 Dec; 8(12):1241-8. PubMed ID: 21854262 [TBL] [Abstract][Full Text] [Related]
8. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate. Doi Y; Shibata N; Shibayama K; Kamachi K; Kurokawa H; Yokoyama K; Yagi T; Arakawa Y Antimicrob Agents Chemother; 2002 Aug; 46(8):2427-34. PubMed ID: 12121914 [TBL] [Abstract][Full Text] [Related]
10. [A new member of CMY type cephalosporinase prevailing in Escherichia coli]. Guan XZ; Liu YN; Luo YP; She DY; Zhou G; Chen LA; Xu YP Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1872-5. PubMed ID: 15631796 [TBL] [Abstract][Full Text] [Related]
11. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials. Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039 [TBL] [Abstract][Full Text] [Related]
12. CMY-2 beta-lactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium. Wu TL; Chia JH; Su LH; Chiu CH; Kuo AJ; Ma L; Siu LK Int J Antimicrob Agents; 2007 Apr; 29(4):410-6. PubMed ID: 17300921 [TBL] [Abstract][Full Text] [Related]
13. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Odeh R; Kelkar S; Hujer AM; Bonomo RA; Schreckenberger PC; Quinn JP Clin Infect Dis; 2002 Jul; 35(2):140-5. PubMed ID: 12087519 [TBL] [Abstract][Full Text] [Related]
14. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece. Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787 [TBL] [Abstract][Full Text] [Related]